SEC 13F Intelligence

Meag Munich Ergo, Kapitalanlagegesellschaft Mbh / PFE

Meag Munich Ergo, Kapitalanlagegesellschaft Mbh’s Pfizer Inc Position

Does Meag Munich Ergo, Kapitalanlagegesellschaft Mbh own Pfizer Inc (PFE)? Yes1.62M shares worth $39M (+1.11% of its 13F portfolio) as of Q2 2025, down from 2.07M shares the prior filed quarter.

Position Value
$39M
Q2 2025
Shares
1.62M
% of Portfolio
+1.11%
Quarters Held
22
currently held

Position History PFE

Reported value by quarter
Q1 ’19: $9MQ1 ’19Q2 ’19: $11MQ3 ’19: $14MQ4 ’19: $4MQ4 ’19Q1 ’20: $69,000Q3 ’20: $587,000Q1 ’21: $906,000Q1 ’21Q4 ’21: $32MQ1 ’22: $37MQ2 ’22: $50MQ2 ’22Q3 ’22: $48MQ4 ’22: $56MQ1 ’23: $56MQ1 ’23Q2 ’23: $56MQ3 ’23: $55MQ4 ’23: $60MQ4 ’23Q1 ’24: $57MQ2 ’24: $57MQ3 ’24: $66MQ3 ’24Q4 ’24: $65MQ1 ’25: $53MQ2 ’25: $39MQ2 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q2 20251.62M$39M+1.11%
Q1 20252.07M$53M+1.54%
Q4 20242.46M$65M+2.05%
Q3 20242.29M$66M+2.08%
Q2 20242.05M$57M+1.91%
Q1 20242.05M$57M+2.06%
Q4 20232.08M$60M+2.27%
Q3 20231.66M$55M+2.40%
Q2 20231.52M$56M+2.42%
Q1 20231.38M$56M+2.66%
Q4 20221.09M$56M+3.00%
Q3 20221.09M$48M+2.91%
Q2 2022949.4K$50M+2.97%
Q1 2022701.7K$37M+2.66%
Q4 2021544.4K$32M+2.27%
Q1 202125.0K$906,000+0.09%
Q3 202016.0K$587,000+0.11%
Q1 20202.1K$69,000+0.02%
Q4 2019112.1K$4M+0.47%
Q3 2019395.0K$14M+0.73%
Q2 2019245.5K$11M+0.84%
Q1 2019219.5K$9M+0.76%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Meag Munich Ergo, Kapitalanlagegesellschaft Mbh’s full portfolio or all institutional holders of PFE.